0001169987-19-000001.txt : 20190514 0001169987-19-000001.hdr.sgml : 20190514 20190513183133 ACCESSION NUMBER: 0001169987-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190513 EFFECTIVENESS DATE: 20190514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-339495 FILM NUMBER: 19819968 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001505512 Regulus Therapeutics Inc. 10628 SCIENCE CENTER DRIVE SUITE 100 SAN DIEGO CA CALIFORNIA 92121 858-202-6300 DELAWARE None None Corporation true Joseph P. Hagan c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Executive Officer Director Daniel R. Chevallard c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Executive Officer Christopher Aker c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Executive Officer David Baltimore c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Director Stelios Papadopoulos c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Director William H. Rastetter c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Director Pascale Witz c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Director Hugh Rosen c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Director Kathryn L. Collier c/o Regulus Therapeutics Inc. 10628 Science Center Dr., Suite 100 San Diego CA CALIFORNIA 92121 Director Pharmaceuticals Decline to Disclose 06b false 2019-05-07 false true true true false 0 H.C. Wainwright Co. 375 None None 430 Park Avenue, 4th Floor New York NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT MD MARYLAND MA MASSACHUSETTS NY NEW YORK false 79343959 16736889 62607070 "Total Offering Amount" includes amounts receivable by the Issuer upon the exercise of certain warrants to purchase the Issuer's Common Stock (assuming no cashless exercise). false 21 2301322 0 "Sales Commissions" includes amounts payable by the Issuer for both the initial closing and the milestone closing. 0 false Regulus Therapeutics Inc. /s/ Christopher Aker Christopher Aker Sr. VP and General Counsel 2019-05-13